Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by National Cerebral and Cardiovascular Center
Sponsor:
Collaborator:
Charitable Trust Mihara Cerebrovascular Disorder Research Promotion Fund
Information provided by (Responsible Party):
Kazunori Toyoda, National Cerebral and Cardiovascular Center
ClinicalTrials.gov Identifier:
NCT02002325
First received: November 28, 2013
Last updated: January 20, 2015
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)